L-THE can decrease the expression of IL-1β, IL-6 and TGF-β though inhibiting the activation of NF‐κB signaling pathway to prevents liver fibrosis (Pérez-Vargas et al., 2016). The gene discussed is NFKB1; the disease is Hepatic fibrosis.